These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 18158304)

  • 1. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver.
    Elmén J; Lindow M; Silahtaroglu A; Bak M; Christensen M; Lind-Thomsen A; Hedtjärn M; Hansen JB; Hansen HF; Straarup EM; McCullagh K; Kearney P; Kauppinen S
    Nucleic Acids Res; 2008 Mar; 36(4):1153-62. PubMed ID: 18158304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LNA-mediated microRNA silencing in non-human primates.
    Elmén J; Lindow M; Schütz S; Lawrence M; Petri A; Obad S; Lindholm M; Hedtjärn M; Hansen HF; Berger U; Gullans S; Kearney P; Sarnow P; Straarup EM; Kauppinen S
    Nature; 2008 Apr; 452(7189):896-9. PubMed ID: 18368051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of microRNAs in vivo with 'antagomirs'.
    Krützfeldt J; Rajewsky N; Braich R; Rajeev KG; Tuschl T; Manoharan M; Stoffel M
    Nature; 2005 Dec; 438(7068):685-9. PubMed ID: 16258535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.
    Bernardo BC; Gao XM; Winbanks CE; Boey EJ; Tham YK; Kiriazis H; Gregorevic P; Obad S; Kauppinen S; Du XJ; Lin RC; McMullen JR
    Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17615-20. PubMed ID: 23047694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.
    Okada H; Honda M; Campbell JS; Takegoshi K; Sakai Y; Yamashita T; Shirasaki T; Takabatake R; Nakamura M; Tanaka T; Kaneko S
    Cancer Sci; 2015 Sep; 106(9):1143-52. PubMed ID: 26122702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locked nucleic acid-based in situ hybridisation reveals miR-7a as a hypothalamus-enriched microRNA with a distinct expression pattern.
    Herzer S; Silahtaroglu A; Meister B
    J Neuroendocrinol; 2012 Dec; 24(12):1492-504. PubMed ID: 22775435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target identification of microRNAs expressed highly in human embryonic stem cells.
    Li SS; Yu SL; Kao LP; Tsai ZY; Singh S; Chen BZ; Ho BC; Liu YH; Yang PC
    J Cell Biochem; 2009 Apr; 106(6):1020-30. PubMed ID: 19229866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting.
    Esau C; Davis S; Murray SF; Yu XX; Pandey SK; Pear M; Watts L; Booten SL; Graham M; McKay R; Subramaniam A; Propp S; Lollo BA; Freier S; Bennett CF; Bhanot S; Monia BP
    Cell Metab; 2006 Feb; 3(2):87-98. PubMed ID: 16459310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-15b and miR-16 regulate TNF mediated hepatocyte apoptosis via BCL2 in acute liver failure.
    An F; Gong B; Wang H; Yu D; Zhao G; Lin L; Tang W; Yu H; Bao S; Xie Q
    Apoptosis; 2012 Jul; 17(7):702-16. PubMed ID: 22374434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122.
    Jopling CL; Norman KL; Sarnow P
    Cold Spring Harb Symp Quant Biol; 2006; 71():369-76. PubMed ID: 17381319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of LNA in microRNA-based cancer diagnostics and therapeutics.
    Stenvang J; Silahtaroglu AN; Lindow M; Elmen J; Kauppinen S
    Semin Cancer Biol; 2008 Apr; 18(2):89-102. PubMed ID: 18295505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA.
    Jopling CL; Yi M; Lancaster AM; Lemon SM; Sarnow P
    Science; 2005 Sep; 309(5740):1577-81. PubMed ID: 16141076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary analysis of microRNA and mRNA expression during phorbol 12-myristate 13-acetate (TPA)-induced differentiation of HL-60 cells.
    Chen A; Luo M; Yuan G; Yu J; Deng T; Zhang L; Zhou Y; Mitchelson K; Cheng J
    Biotechnol Lett; 2008 Dec; 30(12):2045-52. PubMed ID: 18648749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of microRNA families by seed-targeting tiny LNAs.
    Obad S; dos Santos CO; Petri A; Heidenblad M; Broom O; Ruse C; Fu C; Lindow M; Stenvang J; Straarup EM; Hansen HF; Koch T; Pappin D; Hannon GJ; Kauppinen S
    Nat Genet; 2011 Mar; 43(4):371-8. PubMed ID: 21423181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.
    Corsten MF; Miranda R; Kasmieh R; Krichevsky AM; Weissleder R; Shah K
    Cancer Res; 2007 Oct; 67(19):8994-9000. PubMed ID: 17908999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The liver-specific microRNA miR-122: biology and therapeutic potential.
    Filipowicz W; Grosshans H
    Prog Drug Res; 2011; 67():221-38. PubMed ID: 21141732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice.
    Hoekstra M; van der Sluis RJ; Kuiper J; Van Berkel TJ
    J Nutr Biochem; 2012 Jun; 23(6):622-8. PubMed ID: 21764575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locked nucleic acid antisense inhibitor targeting apolipoprotein C-III efficiently and preferentially removes triglyceride from large very low-density lipoprotein particles in murine plasma.
    Yamamoto T; Obika S; Nakatani M; Yasuhara H; Wada F; Shibata E; Shibata MA; Harada-Shiba M
    Eur J Pharmacol; 2014 Jan; 723():353-9. PubMed ID: 24269597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the potential target genes of microRNA-146a induced by PMA treatment in human microvascular endothelial cells.
    Hsieh CH; Rau CS; Jeng SF; Lin CJ; Chen YC; Wu CJ; Lu TH; Lu CH; Chang WN
    Exp Cell Res; 2010 Apr; 316(7):1119-26. PubMed ID: 19944095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of LNA-antimiR-142-3p by Mesenchymal Stem Cells-Derived Exosomes to Breast Cancer Stem Cells Reduces Tumorigenicity.
    Naseri Z; Oskuee RK; Forouzandeh-Moghadam M; Jaafari MR
    Stem Cell Rev Rep; 2020 Jun; 16(3):541-556. PubMed ID: 31898802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.